Shalender Bhasin
Brigham and Women's Hosptial · Brigham and Women's Hospital · Boston Univeristy Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Shalender Bhasin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:50 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07013591 · Nicotinamide Mononucleotide in Patients Undergoing Cardiac SurgeryBrigham and Women's Hospital · recruiting · Cardiac Surgery · principal investigator
- Ph1NCT06882096 · Tracing the Metabolic Flux of Orally Administered NAD+ PrecursorsMetro International Biotech, LLC · recruiting · Healthy Adults · principal investigator
- Ph1NCT06815991 · Phase 1a Single Ascending Dose Study of MIB-725 in Healthy AdultsMetro International Biotech, LLC · recruiting · Healthy Adults · principal investigator
- Ph2NCT05878119 · Effects of MIB-626 With and Without A High-Intensity Multi-Dimensional Exercise Training ProgramMetro International Biotech, LLC · completed · Healthy · principal investigator
- Ph2NCT05759468 · NAD Augmentation in Diabetes Kidney DiseaseBrigham and Women's Hospital · recruiting · Type2diabetes, Diabetic Kidney Disease · principal investigator
- Ph1/Ph2NCT05040321 · Sirtuin-NAD Activator in Alzheimer's DiseaseBrigham and Women's Hospital · completed · Alzheimer's Disease (Incl Subtypes), Dementia · principal investigator
- Ph2NCT05038488 · Phase 2a MIB-626 vs. Placebo COVID-19Metro International Biotech, LLC · completed · Covid19, Stage 1 Acute Kidney Injury · principal investigator
- N/ANCT04772820 · Feasibility of Remote Home Support Coaches (SOCIAL Study)Brigham and Women's Hospital · completed · Malnutrition, Isolation, Depression · principal investigator
- Ph2NCT03716739 · Improving Quality of Life of Prostate Cancer Survivors With Androgen DeficiencyDana-Farber Cancer Institute · completed · Prostate Cancer · principal investigator
- Ph2NCT03576001 · Multimodality Intervention for Function and Metabolism in SCIBrigham and Women's Hospital · completed · Spinal Cord Injuries · principal investigator
- Ph2NCT02499497 · A Selective Androgen Receptor Modulator for Symptom Management in Prostate CancerDana-Farber Cancer Institute · completed · Prostate Cancer · principal investigator
- Ph3NCT02475850 · Strategies to Reduce Injuries and Develop Confidence in EldersBrigham and Women's Hospital · completed · Accidental Falls, Wounds and Injuries · principal investigator
- Ph3NCT01275365 · Optimizing Protein Intake in Older Americans With Mobility LimitationsBrigham and Women's Hospital · completed · Mobility Limitation · principal investigator
- Ph4NCT00512707 · Effect of Testosterone in Men With Erectile DysfunctionBoston University · completed · Erectile Dysfunction, Testosterone Deficiency, Diabetes · principal investigator
- N/ANCT00494208 · TDSM- Testosterone Dose Response in Surgically Menopausal WomenEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · completed · Hysterectomy, Ovariectomy, Menopause · principal investigator
- Ph4NCT00493987 · The Role of 5-alpha Reductase in Mediating Testosterone ActionsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · completed · Healthy · principal investigator
- Ph4NCT00287586 · Testosterone Replacement in Older Men and Atherosclerosis ProgressionBrigham and Women's Hospital · completed · Hypogonadism, Atherosclerosis · principal investigator
- Ph2NCT00260143 · Testosterone and Physical Function in HIV+ MenNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · HIV Associate Weight Loss · principal investigator
- Ph4NCT00240981 · TOM: Testosterone in Older Men With SarcopeniaBoston Medical Center · terminated · Sarcopenia, Hypogonadism, Muscular Diseases · principal investigator
- Ph3NCT00070733 · The Effect of 5-Alpha Reductase on Testosterone in MenEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · unknown · Sex Disorders · principal investigator
- N/ANCT00027092 · Use of a Test That Evaluates How the Body Handles Insulin and GlucoseNational Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections · study chair
- Ph4NCT00009555 · Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal FatNational Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections · study chair
- Ph2NCT00004400 · Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive WomenCharles Drew University of Medicine and Science · completed · HIV Infections, Cachexia · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 6 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Development, Validation, and Harmonization of Methods for Collection and Measurement of NAD+ and Related Metabolites: Application to a Randomized Trial of Patients Undergoing Coronary Artery BypassU01AG089040 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2024 to 2026 · $1,184,917 awarded in 2026Grant number is on one of their registry trials
- Leadership Administrative CoreP30AG031679 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2008 to 2026 · $205,664 awarded in 2026Grant number is on one of their registry trials
- NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled TrialU01AG076789 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2022 to 2026 · $314,717 awarded in 2026Same name and institution; not confirmed by an ID
- Nicotinamide Adenine Dinucleotide Augmentation to Prevent or Reverse the Progression of Alzheimer's Disease in People with Down SyndromeR01AG088141 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2025 to 2026 · $801,611 awarded in 2026Same name and institution; not confirmed by an ID
- Quantitative Assessment of Free Steroid Hormones to Characterize Endometrial Receptivity Towards Improving Pregnancy Outcomes in Frozen Embryo Transfer (FET) CyclesR61HD123436 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2026 · $477,694 awarded in 2026Same name and institution; not confirmed by an ID
- Repurposing a Reverse Transcriptase Inhibitor To Target Retrotransposons and Prevent Alzheimer's Disease in People with Down Syndrome: A Two-Phase UG3/UH3 Clinical Drug Development ProgramUG3AG101657 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2026 · $1,478,201 awarded in 2026Same name and institution; not confirmed by an ID
- Training Program in Patient-Oriented Research in Cardiovascular EndocrinologyT32HL176440 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2025 to 2026 · $406,384 awarded in 2026Same name and institution; not confirmed by an ID
- A Pilot Study to Evaluate the Anabolic Effect of Testosterone on Muscles of the Pelvic Floor in Older Women with Stress Urinary IncontinenceR01DK136904 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2024 to 2025 · $354,840 awarded in 2025Same name and institution; not confirmed by an ID
- A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's DiseaseR01AG071074 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2021 to 2024 · $229,495 awarded in 2024Same name and institution; not confirmed by an ID
- Improving Quality of Life of Prostate Cancer Survivors with Androgen DeficiencyR01AG060539 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2018 to 2023 · $447,317 awarded in 2023Grant number is on one of their registry trials
- Multimodality Intervention to Improve Function and Metabolism in Spinal Cord InjuryR01HD093724 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2018 to 2023 · $446,376 awarded in 2023Grant number is on one of their registry trials
- A selective Androgen Receptor Modulator for Symptom Management in Prostate CancerR01NR014502 · NINR · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2015 to 2019 · $699,109 awarded in 2019Same name and institution; not confirmed by an ID
- Randomized Trial of a Multifactorial Fall Injury Prevention Strategy-SupplementU01AG048270 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2014 to 2019 · $1,300,000 awarded in 2019Grant number is on one of their registry trials
- Position Development Conference for Sarcopenia Definitions and OutcomesR13AG060712 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2018 · $50,000 awarded in 2018Same name and institution; not confirmed by an ID
- Anti-Geronic Factors, GDF11 and Oxytocin, and Aging-Related PhenotypesR56AG052972 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2016 to 2017 · $115,002 awarded in 2017Same name and institution; not confirmed by an ID
- Muscle Mass and Strength Cutpoints in Persons at Risk of Mobility Disability-A1U01AG051421 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2015 to 2017 · $164,566 awarded in 2017Same name and institution; not confirmed by an ID
- Mechanisms of Testosterone ActionR01AG037193 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2010 to 2014 · $455,020 awarded in 2014Same name and institution; not confirmed by an ID
- Optimizing Protein Intake in Older Americans with Mobility LimitationsR01AG037547 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2010 to 2014 · $176,156 awarded in 2014Grant number is on one of their registry trials
- Population-Based Reference Ranges for Estradiol and Estrone in MenR01DK092938 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2012 to 2014 · $530,410 awarded in 2014Same name and institution; not confirmed by an ID
- Mechanism of Myostatin ActionR01DK078512 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2009 to 2013 · $772,174 awarded in 2013Same name and institution; not confirmed by an ID
- A multimodality intervention for mobility limitation in older AmericansR34AG042460 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2012 · $166,154 awarded in 2012Same name and institution; not confirmed by an ID
- Metabolism, Endocrinology and Obesity Training GrantT32DK007201 · NIDDK · BOSTON MEDICAL CENTER · fiscal years 2008 to 2012 · $152,802 awarded in 2012Same name and institution; not confirmed by an ID
- TESTOSTERONE SUPPLEMENTATION FOR MEN WITH SARCOPENIAU01AG014369 · NIA · BOSTON MEDICAL CENTER · fiscal years 2005 to 2011 · $369,469 awarded in 2011Grant number is on one of their registry trials
- Population-Based Reference Ranges for TestosteroneR01AG031206 · NIA · BOSTON MEDICAL CENTER · fiscal years 2008 to 2010 · $479,805 awarded in 2010Same name and institution; not confirmed by an ID
- Testosterone Modulation of Response to Phosphodiesterase InhibitorsR01HD047722 · NICHD · BOSTON MEDICAL CENTER · fiscal years 2005 to 2009 · $348,924 awarded in 2009Grant number is on one of their registry trials
- Mechanisms of Testosterone Effects on Body CompositionR01DK070534 · NIDDK · BOSTON MEDICAL CENTER · fiscal years 2004 to 2007 · $358,745 awarded in 2007Same name and institution; not confirmed by an ID
- Role of 5-alpha Reductase in Testosterone ActionsR01HD043348 · NICHD · BOSTON MEDICAL CENTER · fiscal years 2003 to 2007 · $333,299 awarded in 2007Grant number is on one of their registry trials
- TESTOSTERONE REPLACEMENT AND PHYSICAL FUNCTION IN HIV+ MENP20RR011145 · NCRR · CHARLES R. DREW UNIVERSITY OF MED & SCI · fiscal years 2004 to 2007 · $47,463 awarded in 2007Same name and institution; not confirmed by an ID
- TESTOSTERONE REPLACEMENT ON ATHEROSCLEROSIS PROGRESSION IN OLDER MENM01RR000533 · NCRR · BOSTON UNIVERSITY MEDICAL CAMPUS · fiscal years 2006 to 2007 · $20,489 awarded in 2007Same name and institution; not confirmed by an ID
- TESTOSTERONE REPLACEMENT & PHYSICAL FUNCTION IN HIV+MENR01DK049296 · NIDDK · BOSTON MEDICAL CENTER · fiscal years 1994 to 2005 · $441,471 awarded in 2005Grant number is on one of their registry trials
- Testosterone:Physical Function in Men on HemodialysisR01DK059627 · NIDDK · CHARLES R. DREW UNIVERSITY OF MED & SCI · fiscal years 2001 to 2004 · $125,317 awarded in 2004Same name and institution; not confirmed by an ID
- THE BIOLOGIC EFFECTS OF ANDROGENS IN MEN AND WOMENU54HD041748 · NICHD · CHARLES R. DREW UNIVERSITY OF MED & SCI · fiscal years 2003 to 2004 · $1,224,923 awarded in 2004Same name and institution; not confirmed by an ID
- SARCOPENIA--TESTOSTERONE DOSE RESPONSE IN OLDER MENR01AG014369 · NIA · CHARLES R. DREW UNIVERSITY OF MED & SCI · fiscal years 1997 to 2002 · $50,000 awarded in 2002Same name and institution; not confirmed by an ID
- TESTOSTERONE REPLACEMENT, RESISTANCE EXERCISE AND HIV WASTING SYNDROMES06GM008140 · NIGMS · CHARLES R. DREW UNIVERSITY OF MED & SCI · fiscal years 1996 to 1999 · $67,581 awarded in 1999Same name and institution; not confirmed by an ID
- ANDROGENIC STEROIDS/PROTEIN METABOLISM/MUSCLE STRENGTHR01DK045211 · NIDDK · CHARLES R. DREW UNIVERSITY OF MED & SCI · fiscal years 1992 to 1994 · $8,002 awarded in 1994Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:50 UTC. The ranking covers the 200 most relevant of 118 PubMed records, and a shared surname and initials can bring in a namesake. All 118 on PubMed
- Adverse events associated with testosterone administration.N Engl J Med · 20101,119 citationsRCR 34.6
- The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.N Engl J Med · 19961,100 citationsRCR 37.4
- Testosterone dose-response relationships in healthy young men.Am J Physiol Endocrinol Metab · 2001670 citationsRCR 19.5
- Effects of Testosterone Treatment in Older Men.N Engl J Med · 2016652 citationsRCR 29.7
- Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle.J Clin Endocrinol Metab · 2005394 citationsRCR 11.6
- Cardiovascular Safety of Testosterone-Replacement Therapy.N Engl J Med · 2023367 citationsRCR 48.7
- Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point.J Gerontol A Biol Sci Med Sci · 2014313 citationsRCR 12.9
- Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone.JAMA · 2017299 citationsRCR 12.8
- Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy.Am J Physiol Endocrinol Metab · 2002287 citationsRCR 7.7
- Effects of graded doses of testosterone on erythropoiesis in healthy young and older men.J Clin Endocrinol Metab · 2008278 citationsRCR 8.5